Cite

HARVARD Citation

    Li, X. et al. (n.d.). Glucagon‐like peptide 1‐based therapies and risk of pancreatitis: a self‐controlled case series analysis. Pharmacoepidemiology and drug safety. pp. 234-239. [Online]. 
  
Back to record